BrightAccountsProduction v1.0.0 v1.0.0 2025-04-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is the preparation and retail of pharmaceutical and medicinal products. 29 June 2026 NI068578 2026-03-31 NI068578 2025-03-31 NI068578 2024-03-31 NI068578 2025-04-01 2026-03-31 NI068578 2024-04-01 2025-03-31 NI068578 uk-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 NI068578 uk-curr:PoundSterling 2025-04-01 2026-03-31 NI068578 uk-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 NI068578 uk-bus:FullAccounts 2025-04-01 2026-03-31 NI068578 uk-core:ShareCapital 2026-03-31 NI068578 uk-core:ShareCapital 2025-03-31 NI068578 uk-core:RetainedEarningsAccumulatedLosses 2026-03-31 NI068578 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 NI068578 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2026-03-31 NI068578 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-03-31 NI068578 uk-bus:FRS102 2025-04-01 2026-03-31 NI068578 uk-core:Goodwill 2025-04-01 2026-03-31 NI068578 uk-core:LandBuildings 2025-04-01 2026-03-31 NI068578 uk-core:PlantMachinery 2025-04-01 2026-03-31 NI068578 uk-core:FurnitureFittingsToolsEquipment 2025-04-01 2026-03-31 NI068578 uk-core:MotorVehicles 2025-04-01 2026-03-31 NI068578 uk-core:Goodwill 2025-03-31 NI068578 uk-core:Goodwill 2026-03-31 NI068578 uk-core:CostValuation 2025-03-31 NI068578 uk-core:AdditionsToInvestments 2026-03-31 NI068578 uk-core:CostValuation 2026-03-31 NI068578 uk-core:CurrentFinancialInstruments 2026-03-31 NI068578 uk-core:CurrentFinancialInstruments 2025-03-31 NI068578 uk-core:WithinOneYear 2026-03-31 NI068578 uk-core:WithinOneYear 2025-03-31 NI068578 uk-core:WithinOneYear 2026-03-31 NI068578 uk-core:WithinOneYear 2025-03-31 NI068578 uk-core:AfterOneYear 2026-03-31 NI068578 uk-core:AfterOneYear 2025-03-31 NI068578 uk-core:BetweenOneTwoYears 2026-03-31 NI068578 uk-core:BetweenOneTwoYears 2025-03-31 NI068578 uk-core:BetweenTwoFiveYears 2026-03-31 NI068578 uk-core:BetweenTwoFiveYears 2025-03-31 NI068578 uk-core:MoreThanFiveYears 2026-03-31 NI068578 uk-core:MoreThanFiveYears 2025-03-31 NI068578 2025-04-01 2026-03-31 NI068578 uk-bus:Director1 2025-04-01 2026-03-31 NI068578 uk-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: NI068578

Meigh Pharmacy Limited

Unaudited Financial Statements

for the financial year ended 31 March 2026

Meigh Pharmacy Limited

Company Registration Number: NI068578

BALANCE SHEET

as at 31 March 2026

|  |  | 2026 |  | 2025
|  | Notes | £ |  | £
Fixed Assets

Intangible assets |  | 4 | 3,079,926 |  | 4,027,417
Tangible assets |  | 5 | 285,519 |  | 311,267
Investments |  | 6 | 323,351 |  | 323,314
|  |  | ───────── |  | ─────────
Fixed Assets |  |  | 3,688,796 |  | 4,661,998
|  |  | ───────── |  | ─────────
Current Assets

Stocks |  | 7 | 160,000 |  | 160,000
Debtors |  | 8 | 1,102,749 |  | 146,025
Cash and cash equivalents |  |  | 134,468 |  | 123,696
|  |  | ───────── |  | ─────────
|  |  | 1,397,217 |  | 429,721
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  | 9 | (1,081,604) |  | (1,454,134)
|  |  | ───────── |  | ─────────
Net Current Assets/(Liabilities) |  |  | 315,613 |  | (1,024,413)
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 4,004,409 |  | 3,637,585
Creditors:

amounts falling due after more than one year |  | 10 | (3,305,827) |  | (2,990,359)
|  |  | ───────── |  | ─────────
Net Assets |  |  | 698,582 |  | 647,226
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 1 |  | 1
Retained earnings |  |  | 698,581 |  | 647,225
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 698,582 |  | 647,226
|  |  | ═════════ |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account and Director's Report.

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 29 June 2026

________________________________ |  |  |  |  |
Richard Garvey |  |  |  |  |
Director |  |  |  |  |

Meigh Pharmacy Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 March 2026

1. | General Information
| Meigh Pharmacy Limited is a company limited by shares incorporated in Northern Ireland. 42 Dernaroy Road, Killeavy, Newry, Co. Armagh, BT35 8SP, United Kingdom is the registered office, which is also the principal place of business of the company. . The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the year ended 31 March 2026 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Consolidated accounts
| The company is entitled to the exemption in Section 399 of the Companies Act 2006 from the obligation to prepare group accounts.
| Turnover
| Turnover represents the total invoice value, excluding value added tax, of sales made during the year. Revenue is recognised at the point of sale.
| Goodwill
| Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Balance Sheet and amortised on a straight line basis over its economic useful life of 10 years, which is estimated to be the period during which benefits are expected to arise. On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
| Tangible assets and depreciation
| Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
|  | Land and buildings freehold | - | 4% Straight line
|  | Plant and machinery | - | 15% Straight line
|  | Fixtures, fittings and equipment | - | 20% Reducing Balance
|  | Motor vehicles | - | 25% straight line
| The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
| Investments
| Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the Profit and Loss Account in the year in which it is receivable.
| Stocks
| Stocks are valued at the lower of cost and net realisable value. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Borrowing costs
| Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
| Trade and other creditors
| Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
| Taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
| The average monthly number of employees, including director, during the financial year was 22, (2025 - 22).
|  | 2026 | 2025
|  | Number | Number
| Director | 1 | 1
| Shop Staff | 21 | 21
|  | ───────── | ─────────
|  | 22 | 22
|  | ═════════ | ═════════

4. | Intangible assets
|  | Goodwill | Total
|  | £ | £
| Cost
| At 1 April 2025 | 4,824,908 | 4,824,908
|  | ───────── | ─────────
| At 31 March 2026 | 4,824,908 | 4,824,908
|  | ───────── | ─────────
| Amortisation
| At 1 April 2025 | 797,491 | 797,491
| Charge for financial year | 947,491 | 947,491
|  | ───────── | ─────────
| At 31 March 2026 | 1,744,982 | 1,744,982
|  | ───────── | ─────────
| Net book value
| At 31 March 2026 | 3,079,926 | 3,079,926
|  | ═════════ | ═════════
| At 31 March 2025 | 4,027,417 | 4,027,417
|  | ═════════ | ═════════

5. | Tangible assets
|  | Land and | Plant and | Fixtures, | Motor | Total
|  | buildings | machinery | fittings and | vehicles |
|  | freehold |  | equipment |  |
|  | £ | £ | £ | £ | £
| Cost
| At 1 April 2025 | 236,020 | 228,288 | 167,453 | 74,260 | 706,021
| Additions | - | - | - | 29,750 | 29,750
| Disposals | - | - | - | (58,760) | (58,760)
|  | ───────── | ───────── | ───────── | ───────── | ─────────
| At 31 March 2026 | 236,020 | 228,288 | 167,453 | 45,250 | 677,011
|  | ───────── | ───────── | ───────── | ───────── | ─────────
| Depreciation
| At 1 April 2025 | 19,704 | 182,984 | 129,431 | 62,635 | 394,754
| Charge for the financial year | 2,338 | 34,243 | 7,604 | 11,313 | 55,498
| On disposals | - | - | - | (58,760) | (58,760)
|  | ───────── | ───────── | ───────── | ───────── | ─────────
| At 31 March 2026 | 22,042 | 217,227 | 137,035 | 15,188 | 391,492
|  | ───────── | ───────── | ───────── | ───────── | ─────────
| Net book value
| At 31 March 2026 | 213,978 | 11,061 | 30,418 | 30,062 | 285,519
|  | ═════════ | ═════════ | ═════════ | ═════════ | ═════════
| At 31 March 2025 | 216,316 | 45,304 | 38,022 | 11,625 | 311,267
|  | ═════════ | ═════════ | ═════════ | ═════════ | ═════════

6. | Investments
|  | Group and | Total
|  | participating |
|  | interests/ |
|  | joint ventures |
| Investments | £ | £
| Cost
| At 1 April 2025 | 323,314 | 323,314
| Additions | 37 | 37
|  | ───────── | ─────────
| At 31 March 2026 | 323,351 | 323,351
|  | ───────── | ─────────
| Net book value
| At 31 March 2026 | 323,351 | 323,351
|  | ═════════ | ═════════
| At 31 March 2025 | 323,314 | 323,314
|  | ═════════ | ═════════

7. | Stocks | 2026 | 2025
|  | £ | £
| Finished goods and goods for resale | 160,000 | 160,000
|  | ═════════ | ═════════
| The replacement cost of stock did not differ significantly from the figures shown.

8. | Debtors | 2026 | 2025
|  | £ | £
| Trade debtors | 130,975 | 123,867
| Other debtors | 934,265 | 2,125
| Taxation (Note 11) | 33,392 | 16,500
| Prepayments and accrued income | 4,117 | 3,533
|  | ───────── | ─────────
|  | 1,102,749 | 146,025
|  | ═════════ | ═════════

9. | Creditors | 2026 | 2025
| Amounts falling due within one year | £ | £
| Bank loan | 421,572 | 339,024
| Trade creditors | 297,270 | 209,339
| Amounts owed to group undertakings | 162,378 | 609,251
| Taxation (Note 11) | 61,261 | 21,089
| Director's current account | 131,298 | 270,931
| Other creditors | 3,325 | -
| Accruals | 4,500 | 4,500
|  | ───────── | ─────────
|  | 1,081,604 | 1,454,134
|  | ═════════ | ═════════

10. | Creditors | 2026 | 2025
| Amounts falling due after more than one year | £ | £
| Bank loan | 3,305,827 | 2,750,359
| Other loans | - | 240,000
|  | ───────── | ─────────
|  | 3,305,827 | 2,990,359
|  | ═════════ | ═════════
| Loans
| Repayable in one year or less, or on demand (Note 9) | 421,572 | 339,024
| Repayable between one and two years | 421,572 | 678,048
| Repayable between two and five years | 1,264,716 | 1,314,144
| Repayable in five years or more | 1,619,539 | 758,167
|  | ───────── | ─────────
|  | 3,727,399 | 3,089,383
|  | ═════════ | ═════════

11. | Taxation | 2026 | 2025
|  | £ | £
| Debtors:
| VAT | 33,392 | 16,500
|  | ═════════ | ═════════
| Creditors:
| Corporation tax | 56,377 | 18,035
| PAYE / NI | 4,884 | 3,054
|  | ───────── | ─────────
|  | 61,261 | 21,089
|  | ═════════ | ═════════

12. | Related party transactions
| The company has availed of the exemption under FRS 102 Section 1A in relation to the disclosure of transactions with group undertakings.